WHO adds first mpox vaccine to prequalification list The decision is expected to facilitate timely access to Bavarian Nordic’s Imvanex
McMaster drug trial receives more than $6m to test smallpox vaccine against mpox Children accounted for the majority of mpox cases and deaths in the DRC since June 2023